Evidence map›Paper›PMID 42341040›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Temperature and developmental stage govern intestinal susceptibility to human coronavirus 229E.

Aleksandra Synowiec, Laurensius Kevin Lie, Katarzyna Owczarek, Nina Johannesson, Nina Mickiewicz, Heng-Chang Chen, Artur Szczepański, Madison S Strine, Renata B Filler, Maciej Borowiec and 14 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Temperature and developmental stage govern intestinal susceptibility to human coronavirus 229E.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Aleksandra Synowiec *Virogenetics Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.
Laurensius Kevin Lie *Virogenetics Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.ORCID 0000-0001-9960-8507
Katarzyna OwczarekVirogenetics Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.ORCID 0000-0002-2166-4688
Nina JohannessonOrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam University Medical Center, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
Nina MickiewiczVirogenetics Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.ORCID 0009-0009-4382-6084
Heng-Chang ChenQuantitative Virology Research Group, Population Diagnostics Center, Łukasiewicz Research Network-PORT Polish Center for Technology Development, Wrocław 54-066, Poland.ORCID 0000-0003-2117-7385
Artur SzczepańskiVirogenetics Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.
Madison S StrineDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0001-8572-1314
Renata B FillerDepartment of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510.
Maciej BorowiecDepartment of Clinical and Laboratory Genetics, Medical University of Lodz, Lodz 92-213, Poland.ORCID 0000-0003-2812-5676
Michał PietrusińskiDepartment of Clinical and Laboratory Genetics, Medical University of Lodz, Lodz 92-213, Poland.
Izabela DróżdżDepartment of Clinical and Laboratory Genetics, Medical University of Lodz, Lodz 92-213, Poland.ORCID 0000-0003-1956-5063
Agnieszka RobaszkiewiczDepartment of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz 90-236, Poland.ORCID 0000-0002-6265-5585
Michał BochenekVirogenetics Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.ORCID 0000-0001-8870-3840
Matthias ZilbauerDepartment of Pediatrics, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, United Kingdom.
Justyna RymarowiczDepartment of General Surgery, Jagiellonian University Medical College, Kraków 30-688, Poland.ORCID 0000-0002-6713-5255
Michał PędziwiatrDepartment of General Surgery, Jagiellonian University Medical College, Kraków 30-688, Poland.
Liza KonnikovaDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0003-4804-5497
Craig B WilenDepartment of Laboratory Medicine, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0003-2495-9403
Dasja PajkrtOrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam University Medical Center, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.ORCID 0000-0002-5232-8206
Katja C WolthersOrganoVIR Labs, Department of Medical Microbiology, Amsterdam University Medical Center, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
Carlemi CalitzOrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam University Medical Center, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.ORCID 0000-0001-9751-1162
Adithya SridharOrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam University Medical Center, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
Krzysztof PyrcVirogenetics Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland.ORCID 0000-0002-3867-7688

Funding

EC | EU4Health (UE pela Saúde) 101102733EC | Horizon 2020 Framework Programme (H2020) 812673EC | Horizon 2020 Framework Programme (H2020) 953201Era-Net ICRAD ERAnet ICRAD-projectNarodowe Centrum Nauki (NCN) 2019/35/N/NZ6/04057Polsko-Amerykanska Komisja Fulbrighta (Fulbright Poland) PL/2023/21/JR
6 · The paper itself

Abstract

Human coronaviruses have been primarily associated with upper respiratory tract infections, yet cases of gastrointestinal symptoms in COVID-19 patients have highlighted their potential to cause systemic disease. Here, we detail the infection of intestinal epithelia by an endemic, low-pathogenic human coronavirus, human alphacoronavirus 229E, using patient-derived human intestinal enteroids (HIEs) from donors of various ages. Using fetal, pediatric, and adult HIEs, we investigated how physiologically relevant temperatures: 37 °C and 32 °C, reflecting gastrointestinal and upper-airway conditions, respectively, modulate epithelial responses and viral infection dynamics. We show that there is temperature-dependent transcriptional reprogramming, indicating strong temperature-dependent regulation of virus replication and epithelial responses. Among the seasonal coronaviruses tested, only HCoV-229E productively infects HIEs. At 32 °C, HCoV-229E replicates efficiently in enteroids from all donor ages and releases high titers of infectious progeny. In contrast, at 37 °C, productive replication is largely confined to fetal and a subset of pediatric tissues, revealing a developmental and temperature-sensitive restriction on infection. Confocal and flow cytometry analyses identify enterocytes as the primary target cells for HCoV-229E. Furthermore, we show that camostat, a serine protease inhibitor, significantly reduces HCoV-229E replication in HIEs, confirming a critical role for host serine protease activity. Collectively, these findings establish HIEs as a relevant model for HCoV-229E-host interactions and reveal temperature- and age-dependent determinants governing intestinal permissiveness to this seasonal coronavirus.

Indexed as

Coronavirus 229E, HumanCoronavirus InfectionsIntestinal MucosaIntestinesHumansTemperatureVirus ReplicationcoronavirusHCoV-229Ehost restrictionhuman intestinal enteroidsviral tropism

Identifiers

PMID42341040
PMCPMC13320717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.